The UK In-Vitro Diagnostics (IVD) market is booming, projected to reach £7.27 billion by 2033 with a CAGR of 7.59%. Driven by chronic disease prevalence and technological advancements, this report analyzes market segments, key players (Siemens, Roche, Abbott), and future trends in clinical chemistry, molecular diagnostics, and more. Discover key insights and growth opportunities in the UK IVD sector.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.